Evidence mapPaperPMID 41314823Full record

Observational studyBMJ open2025

Assessment of validity, reliability, responsiveness and acceptability of seven Dutch-Flemish PROMIS computerised adaptive tests (CATs) in Dutch people with type 2 diabetes: an observational and qualitative study.

Lenka Groeneveld, Caroline B Terwee, Esmee M van der Willik, Frans J van Ittersum, Marlous Langendoen-Gort, Fleur Pals, Marieke T Blom, Joline W J Beulens, Petra J M Elders, Femke Rutters

Abstract readObservational StudyValidation Study
In one paragraph

Observational study in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lenka GroeneveldEpidemiology & Data Science, Amsterdam UMC, Amsterdam, Netherlands l.groeneveld@amsterdamumc.nl.ORCID http://orcid.org/0000-0002-2901-6677
Caroline B TerweeEpidemiology & Data Science, Amsterdam UMC, Amsterdam, Netherlands.
Esmee M van der WillikEpidemiology & Data Science, Amsterdam UMC, Amsterdam, Netherlands.ORCID http://orcid.org/0000-0001-9457-5857
Frans J van IttersumDepartment of Nephrology, Amsterdam University Medical Center, Amsterdam, Netherlands.
Marlous Langendoen-GortAmsterdam Public Health research institute, Health Behaviors & Chronic Diseases, Amsterdam UMC, Amsterdam, Netherlands.
Fleur PalsEpidemiology & Data Science, Amsterdam UMC, Amsterdam, Netherlands.
Marieke T BlomAmsterdam Public Health research institute, Health Behaviors & Chronic Diseases, Amsterdam UMC, Amsterdam, Netherlands.
Joline W J BeulensEpidemiology & Data Science, Amsterdam UMC, Amsterdam, Netherlands.ORCID http://orcid.org/0000-0002-4181-0937
Petra J M EldersAmsterdam Public Health research institute, Health Behaviors & Chronic Diseases, Amsterdam UMC, Amsterdam, Netherlands.
Femke RuttersEpidemiology & Data Science, Amsterdam UMC, Amsterdam, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to assess construct validity against commonly used patient-reported outcome measures (PROMs), test-retest reliability and responsiveness of seven Dutch-Flemish Patient-Reported Outcomes Measurement Information System (PROMIS) computerised adaptive testing (CATs) in Dutch adults with type 2 diabetes (T2D), and assess their acceptability in healthcare providers and people with T2D.

designA cross-sectional observational study in people with T2D and qualitative study involving both people with T2D and healthcare professionals.

settingParticipants with T2D were recruited from the ongoing Hoorn Diabetes Care System cohort in the West-Friesland area of the Netherlands. Additionally, people with T2D and advanced chronic kidney disease were recruited at the outpatient clinics of Amsterdam University Medical Centre and 'Niercentrum aan de Amstel', both in the Amsterdam area of the Netherlands. The healthcare professionals involved in the qualitative part were recruited at the Amsterdam University Medical Centre.

participants314 people with T2D (age 64.0±10.8 years, 63.7% men). PRIMARY AND SECONDARY OUTCOME MEASURES: Participants completed seven PROMIS CATs (assessing (1) Physical Function, (2) Pain Interference, (3) Fatigue, (4) Sleep Disturbance, (5) Anxiety, (6) Depression and (7) Ability to Participate in Social Roles and Activities), and PROMs measuring similar constructs. After 2 weeks and 6 months, participants completed the CATs measures again, together with seven Global Rating Scales (GRS) on perceived change in each domain. Construct validity was assessed using Pearson's correlations. Test-retest reliability was assessed by the intraclass correlation coefficient (ICC). Measurement error was assessed by the standard error of measurement (SEM) and minimal detectable change (MDC). Responsiveness was assessed by correlations between change scores on the PROMIS CAT and GRS. Acceptability was assessed through focus groups and interviews in healthcare providers and people with T2D.

resultsExcept for Fatigue, all PROMIS CAT domains demonstrated sufficient construct validity, since ≥75% of the results was in accordance with a priori hypotheses. All seven PROMIS CATs showed sufficient test-retest reliability (ICCs 0.73-0.91). SEM and MDC ranged from 2.1 to 2.7 and from 5.7 to 7.4, respectively. Responsiveness was rated as insufficient in this study design as there was almost no change in participants' own rating of their health compared with 6 months ago according to a global rating of change.During the focus groups and interviews, healthcare providers and people with T2D agreed that CATs could serve as a conversation starter in routine care, but should never replace personal consultations with a doctor. If implemented, participants would be willing to spend 15 min to complete the PROMIS CATs.

conclusionsThe PROMIS CATs showed sufficient construct validity and test-retest reliability in most domains in people with T2D. Responsiveness needs to be evaluated in a population with poorer diabetes control or in a study design with longer follow-up. The CATs are well accepted to be used in care to identify relevant topics, but should not replace personal contact with the doctor.

Indexed as

Diabetes Mellitus, Type 2Patient Reported Outcome MeasuresAgedCross-Sectional StudiesEuropean PeopleFemaleHumansMaleMiddle AgedNetherlandsPsychometricsQualitative ResearchQuality of LifeReproducibility of ResultsDiabetes Mellitus, Type 2General diabetesPatient Reported Outcome Measures

Identifiers

PMID41314823
PMCPMC12684131

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.